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Gender differences in the relative risk of developing metabolic complications, such as 
insulin resistance or non-alcoholic fatty liver disease (NAFLD), have been reported. The 
deregulation of glycerol metabolism partly contributes to the onset of these metabolic 
diseases, since glycerol constitutes a key substrate for the synthesis of triacylglycerols 
(TAGs) as well as for hepatic gluconeogenesis. The present mini-review covers the sex- 
related differences in glycerol metabolism and aquaglyceroporins (AQPs) and its impact 
in the control of adipose and hepatic fat accumulation as well as in whole-body glucose 
homeostasis. Plasma glycerol concentrations are increased in women compared to men 
probably due to the higher lipolytic rate and larger AQP7 amounts in visceral fat as well 
as the well-known sexual dimorphism in fat mass with women showing higher adiposity. 
AQP9 represents the primary route for glycerol uptake in hepatocytes, where glycerol is 
converted by the glycerol-kinase enzyme into glycerol-3-phosphate, a key substrate for 
de novo synthesis of glucose and TAG. In spite of showing similar hepatic AQP9 protein, 
women exhibit lower hepatocyte glycerol permeability than men, which might contribute 
to their lower prevalence of insulin resistance and NAFLD.
Keywords: glycerol, metabolism, aquaglyceroporins, obesity, insulin resistance, fatty liver disease, gender 
dimorphism
GLYCeROL iS An iMPORTAnT vARiABLe in MeTABOLiC AnD 
eneRGY HOMeOSTASiS
Glycerol represents a direct source of glycerol-3-phosphate (G3P), an important metabolite for the 
control of fat accumulation since it is required for the synthesis of triacylglycerols (TAGs), and 
for glucose homeostasis, given that it constitutes a major substrate for gluconeogenesis during 
states of negative energy balance, such as fasting or exercise (1, 2). Circulating free glycerol results 
from lipolysis, diet-derived glycerol, or glycerol reabsorbed in proximal renal tubules. In addition, 
intracellular glycerol also derives from glucose, via glycolysis, or through the conversion of pyruvate, 
lactate, and alanine to G3P, a pathway termed glyceroneogenesis occurring in the white and brown 
adipose tissues, and in the liver to support TAG synthesis, particularly in situations when cycling of 
TAG is increased (1).
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Aquaglyceroporins (AQPs), protein channels allowing trans-
port of glycerol, other small neutral solutes and water across 
membranes, are emerging as important players in metabolic and 
energy homeostasis with important implications in adiposity 
and insulin resistance control. In line with the proven prefer-
ence of carbohydrate metabolism in men and lipid in women, 
important quantitative sexual-specific differences in AQPs 
and glycerol as metabolic substrate are being observed both 
in health and disease (3). Here, we will discuss the metabolic 
relevance and gender dimorphism of AQPs in fat and hepatic 
glycerol homeostasis with a particular focus on some worrisome 
metabolic disorders.
SeXUAL DiMORPHiSM OF 
AQUAGLYCeROPORin eXPReSSiOn AnD 
GLYCeROL MeTABOLiSM
white Adipose Tissue and Liver Are 
Central in Glycerol Homeostasis
During states of negative energy balance, such as fasting and 
exercise, adipocyte lipolysis is increased by the activation of 
adipose TAG lipase (ATGL) and hormone-sensitive lipase (HSL). 
Breakdown of TAG into free fatty acids (FFA) and monoacylglyc-
erol (MAG) is initiated by ATGL and HSL, whereas the final step 
of converting MAG into FFA and glycerol is catalyzed by MAG 
lipase (4). Lipolysis occurs during low circulating insulin and 
under hormonal stimulation by catecholamines, through lipolytic 
β-adrenoceptors (β1, β2, and β3), and natriuretic peptides. Up to 
65% of generated FFA is re-esterified back into TAG within white 
adipose tissue, whereas most of the generated glycerol is released 
from adipocytes to provide energy needs in other tissues, even in 
the fasted state. The activity of glycerol-kinase (GK), the enzyme 
catalyzing the initial phosphorylation of glycerol into G3P, in 
adipocytes is very low and the G3P used for TAG re-synthesis is 
mostly derived from the glyceroneogenesis (5).
The liver is responsible for 70–90% of the whole-body glycerol 
metabolism. Glycerol imported by hepatocytes is phosphorylated 
into G3P by GK enzyme. Depending on the metabolic state, 
G3P is used for lipogenesis (TAG) or gluconeogenesis, the latter 
process being the one using most of the generated G3P (1). G3P 
for TAG synthesis is also made from pyruvate by the enzymatic 
activity of pyruvate carboxylase (PC) and phosphoenolpyruvate 
carboxykinase (PEPCK), an enzyme whose activity is reduced 
by insulin and other hormones (Figure  1). The proportion of 
glycerol that ends up in TAG synthesis vs. gluconeogenesis is 
correlated with a number of parameters whose actions mostly 
convey gender-based differences (3). In general, the extent of G3P 
used for gluconeogenesis increases as the fasting period lasts.
Gender-Specific Differences in Glycerol 
Metabolism
Hepatic glycerol utilization involves sexual dimorphism, a trait 
reflecting the preference of carbohydrate metabolism in men and 
lipid in women. In healthy humans, important gender-specific 
differences in glycerol metabolism exist in states of increased 
energy demand, such as hypoglycemia, fasting, or exercise (3).
FiGURe 1 | Gender-specific differences in aquaglyceroporins and 
glycerol metabolism in adipose tissue and liver during fasting. In 
cellular membranes, aquaporins assemble as a tetramer, with each monomer 
forming a functionally independent pore that allows the movement of water 
and/or other small solutes, such as glycerol, in the case of 
aquaglyceroporins. Women exhibit higher circulating glycerol concentrations 
than men during fasting, probably due to the higher percentage of fat mass 
characteristic of females as well as the higher lipolytic rate and AQP7 
abundance in visceral adipose tissue. AQP9 represents the primary route for 
glycerol uptake in hepatocytes, where glycerol is converted to glycerol-3-
phosphate by the GK enzyme for the de novo synthesis of glucose and 
triacylglycerols. Despite similar hepatic AQP9 expression, women exhibit 
lower hepatocyte glycerol permeability than men, which might contribute to 
the lower prevalence of NAFLD in women. The conditions showing 
upregulation (red arrows) or downregulation (green arrows) in women 
compared to men are indicated. FFA, free fatty acids, G6PC, glucose-6-
phosphatase; GK, glycerol kinase; GLUT, glucose transporter; NAFLD, 
non-alcoholic fatty liver disease; PEP, phosphoenolpyruvate; PCK1, 
phosphoenolpyruvate carboxykinase variant 1; TAG, triacylglycerols.
During hypoglycemia, despite the higher neuroendocrine 
and autonomic nervous system (ANS) responses exhibited by 
females compared to males (6), females have higher plasma 
glycerol compared to males (Figure 1). This could be explained 
by a greater rate in glycerol turnover resulting from increased 
peripheral fat accumulation and higher percent of fat mass 
characterizing females. Moreover, female adipose tissue shows 
higher sensitivity to lipolytic hormones, such as epinephrine, 
norepinephrine, and growth hormone, compared to men (7). 
Greater plasma glycerol in women is also attributed to the higher 
lipolysis and fat oxidation exhibited by women during hypogly-
cemia compared to men.
After 72-h fasting, correlating with the sex-based differences 
in plasma glucose and FFA, women showed significantly higher 
plasma glycerol levels compared to men (8). Changes in glycerol 
metabolism between genders may relate to different sensitivities 
to insulin and epinephrine, two hormones inhibiting and stimu-
lating lipolysis, respectively, and leptin, a hormone with lipolytic 
effects (3, 4, 9). Obesity is associated with higher lipolytic rates 
leading to increased circulating FFA and glycerol (10); however, 
the sex-specific relevance of these hormones in glycerol homeo-
stasis remains to be fully assessed.
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Gender-related differences in lipolytic glycerol utilization also 
exist during physical exercise. After 90 min of moderate exer-
cise, women have significantly higher levels of plasma glycerol 
as compared to men, a counterregulatory response consistent 
with the reduced carbohydrate and increased lipid utilization 
characterizing women (6). Changes in ANS responses have been 
suggested to be the major factor responsible of this metabolic 
finding (3). No effect of the cyclic fluctuations in estrogen and 
progesterone occurring during the menstrual cycle was observed 
as regards the systemic rates of glycerol during 90 min of moder-
ate exercise (11).
Aquaglyceroporins, Metabolic Gateways 
Facilitating the Transport of Glycerol 
Across the Cell Membrane in Adipose 
Tissue and Liver
Aquaglyceroporins (AQP3, 7, 9, and 10), a subgroup of the aqua-
porin family of channel proteins allowing transport of glycerol 
and some other neutral solutes besides to water across biological 
membranes, have emerged as important metabolic gateways in 
adiposity and insulin resistance control (12–14).
AQP7 represents the main pathway in facilitating release 
of lipolytic glycerol from adipocytes (15–21), although some 
authors have not been able to detect AQP7 expression in fat 
cells (22). Nonetheless, other glycerol channels, such as AQP3, 
AQP10, and the more recently identified AQP11, contribute 
to glycerol efflux from fat, but to a lower extent (19, 20, 23). 
Adipocytes also express AQP9, an AQP believed to mediate 
the entry of glycerol into fat tissue (19), and AQP5, a water 
channel involved in the process of adipocyte differentiation 
(24). The expression of AQPs shows fat depot differences with 
visceral fat exhibiting higher expression of AQP3 and AQP7, 
which might reflect an overall increase in lipolytic rate and 
glycerol release in this fat depot, and subcutaneous fat showing 
lower AQP7 levels pointing to the promotion of an intracel-
lular glycerol accumulation and a progressive adipocyte 
hypertrophy (17, 19, 25, 26).
Glycerol released by adipocytes, via the bloodstream, is 
imported by hepatocytes through AQP9, the principal facilita-
tive pathway in liver uptake of glycerol (27, 28) localized at the 
sinusoidal domain of the cell membrane, facing the spaces of 
Disse (29). In the rodent liver, AQP9 displays a heterogeneous 
expression pattern. Especially in females, hepatocyte AQP9 
protein expression is greater in the area surrounding the central 
vein by gradually declining toward the periportal area. Sexual 
dimorphism is also indicated by female rats having significantly 
lower levels of hepatic AQP9 protein compared with males in 
both fed and fasting conditions (30, 31). In addition to AQP9, 
although at low levels, human hepatocytes also express three 
other AQPs, AQP3, AQP7, and AQP10 (10). The sinusoidal 
uptake of glycerol is of critical importance as glycerol utilization 
by the liver is rate limited at the membrane permeation step (32). 
GK catalyzes the initial step for the conversion of the imported 
glycerol into  glycerol-3-phosphate, an important substrate for 
de  novo synthesis of glucose (gluconeogenesis) and/or TAG 
(lipogenesis) (Figure 1).
Hormonal Regulation and Sexual 
Dimorphism of Fat and Liver 
Aquaglyceroporins
The coordinated regulation of AQPs in adipocytes and hepato-
cytes is pivotal in maintaining the control of fat accumulation in 
adipose tissue and liver, as well as whole-body glucose homeo-
stasis. In this sense, Aqp7 gene disruption leads to obesity (33, 
34), and Aqp9 deficiency is related to a defective hepatic glycerol 
metabolism in mice (2). However, the interaction with the genetic 
background of the transgenic mice as well as the age of the 
experimental animals appears to influence these metabolic phe-
notypes. In this regard, Aqp7-deficient mice backcrossed into the 
C57BL/6N genetic background develop adult-onset obesity (33, 
35) but not in the young state (22, 36), whereas Aqp7-knockout 
mice generated in CD1 mice did not exhibit excess body weight 
but showed an increase in whole-body fat content (34). In the 
same line, Aqp9 deletion in leptin receptor-deficient db/db mice 
in a mixed C57BL/6 ×  C57BLKS genetic background reduces 
postprandial blood glucose levels (2), whereas in Aqp9-deficient 
C57BL/6 db/db mice elevates plasma glucose and does not allevi-
ate hepatosteatosis (37).
In rodents, insulin represses adipose Aqp7 and hepatic Aqp9 
gene expression through the negative insulin response element 
(IRE) in their gene promoters (15, 38). Rodent models of insulin 
resistance, such as streptozotocin-induced diabetic rats or 
genetically obese db/db mice, have an increase in hepatic AQP9 (38, 
39). Gender-specific differences have been described in hepatic 
AQP9 modulation by insulin in rodents. During fasting, hepatic 
AQP9 protein increased 2.6-fold in male compared to female rats 
(31). Coordinately, plasma glycerol levels remained unchanged 
with starvation in male rats, whereas they were increased in female 
rats. Consistent with the major role played by AQP9 in rodent 
liver glycerol import, the different responses to starvation were 
paralleled by higher hepatic glycerol permeability in starved male 
rats compared with starved females. Interestingly, ovariectomy 
led to a starvation-response pattern identical to that observed in 
male rats with increased hepatic AQP9 expression and unchanged 
plasma glycerol levels. These results, together with those obtained 
with cultured hepatocytes challenged with 17β-estradiol and an 
estrogen receptor β-agonist, led to the hypothesis that the sex-
specific regulation of AQP9 during starvation contributes to 
the higher plasma glycerol levels characterizing females during 
fasting (31). A recent work showed that the mRNA expression of 
Aqp9 in male rat periportal hepatocytes was reduced in response 
to the peroxisome proliferator-activated receptor α (PPARα) (40). 
Contrary to what is observed in rodents, insulin upregulates the 
expression of AQPs in human HepG2 hepatocytes, a control that 
occurs through the activation of the PI3K/Akt/mTOR pathway 
(19). In liver sections of obese patients, AQP3 and AQP7 
show a cytoplasmatic distribution surrounding lipid droplets 
(19), while a strong immunoreactivity of AQP9 appears in the 
basolateral membrane of the hepatocytes (10, 19). Thus, insulin-
mediated elevation of AQP3 and AQP7 may reflect an increase 
in intrahepatocellular TAG content induced by the hormone 
in HepG2 hepatic cell line, whereas insulin-induced AQP9 
upregulation seems to facilitate glycerol import by hepatocytes. 
FiGURe 2 | Proposed working model for the role of aquaglyceroporins in the onset of insulin resistance and non-alcoholic fatty liver disease 
(nAFLD). Insulin and leptin are regulatory factors for the expression of AQP3 and AQP7 glycerol channels in adipocytes and AQP9 in hepatocytes. Plasma insulin 
and leptin concentrations change in accordance to the nutritional state and adiposity, respectively, and therefore, the expression of aquaglyceroporins in adipose 
tissue and liver increases or decreases in relation to the nutritional needs and excess fat mass. In the setting of obesity-associated insulin resistance and NAFLD, 
AQP3 and AQP7 are overexpressed in the adipose tissue, despite the hyperleptinemia. Consequently, glycerol output from fat cells and glycerol use for hepatic 
gluconeogenesis and lipogenesis increase. The reduced AQP9 expression and glycerol permeability in the liver of obese patients with insulin resistance seems to be 
a defensive mechanism to prevent a further increase in hepatic steatosis and hyperglycemia. ATGL, adipose tissue triacylglycerol lipase; HSL, hormone-sensitive 
lipase; FFA, free fatty acids; GK, glycerol kinase; TAG, triacylglycerol.
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This may explain why obese patients with type 2 diabetes (T2D) 
have decreased hepatic AQP9, compatible with a compensatory 
mechanism aimed at reducing the glycerol entry into hepatocytes 
and further enhancing the development of hyperglycemia 
(Figure 2) (10, 19). The mRNA expression of AQP9 in HepG2 
cells was modulated by the AMP-activated protein kinase 
(AMPK), a known energy sensor in cells, via forkhead box a2 
(41). Under physiological conditions, AMPK activation occurs 
in response to an increase in the intracellular AMP/ATP ratio. 
Connection between obesity and secondary development of T2D 
and a common SNP (A953G) in the AQP7 promoter was reported 
in Caucasian individuals. AQP7 gene transcription was decreased 
due to the impaired C/EBPβ binding to the promoter triggered by 
the polymorphism (42). The unique reported rare case of human 
AQP7 deficiency was not associated with the onset of obesity and 
diabetes as occurs in Aqp7-knockout animals (43). Interestingly, 
this AQP7-deficient individual lacked exercise-induced increase 
in adipose tissue glycerol release in spite of elevated plasma levels 
of the lipolytic hormone noradrenaline. Interestingly, a gender-
specific effect of physical training on adipose AQP7 expression 
has been reported with women showing higher abundance of 
AQP7 compared with men (44) and increasing the abundance 
of AQP7 in abdominal subcutaneous fat depot after a 10-week 
endurance exercise program (45).
Leptin, an adipocyte-derived hormone with lipolytic action, 
has been shown to repress the AQP7 and AQP9 protein expression 
via the PI3K/Akt/mTOR signaling cascade in differentiated 
human adipocytes and hepatocytes, respectively (19). The 
lipolytic stimulation with leptin and catecholamines induce the 
translocation of AQP7 from the cytoplasm, surrounding lipid 
droplets, to the plasma membrane, favoring glycerol release 
from adipocytes (19, 46, 47). Nonetheless, the direct stimulation 
of adipocytes with catecholamines (19, 48) or leptin (19, 47) 
downregulates the mRNA and protein expression of AQP7 in 
adipocytes, suggesting a negative feedback regulation of AQP7 
in lipolytic states to restrict glycerol release from adipocytes 
in order to prevent the depletion of fat stores. The sexual 
dimorphism in leptin regulation of human adipose and hepatic 
AQPs warrants investigation as women have two to three times 
higher levels of circulating leptin compared with men (49). Leptin 
showed a distinct mechanism of action toward rodent AQPs. 
Acute leptin treatment induced the translocation of AQP3 and 
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AQP7 to lipid droplets and the plasma membrane of murine 
adipocytes, respectively, and facilitation of glycerol mobilization 
after lipolysis was therefore reasonably suggested (47). Chronic 
leptin administration in male leptin-deficient ob/ob mice 
down-regulated adipose AQP3 and AQP7 at the same time as 
it upregulated hepatic AQP9 in parallel with the improvement 
of obesity and hepatosteatosis observed in this genetically obese 
animal model (47). Positive correlation between PPARγ and 
adipose AQP3 and AQP7 and hepatic AQP9 was found regarding 
the regulatory effect exerted by leptin on mouse AQPs (47).
AQP9 AnD ALTeReD HePATOCYTe 
iMPORT OF GLYCeROL, A new 
inTeRSeCTinG COMPOnenT in  
nAFLD/nASH
Non-alcoholic fatty liver disease (NAFLD) is characterized 
by ectopic accumulation of TAG in hepatocytes in response to 
metabolic, toxic, and viral insults (50), and it constitutes the lead-
ing cause of chronic liver disease with an estimated prevalence 
of 20–40% in Western countries (51). NAFLD may evolve to the 
inflammatory-fibrogenic form, the non-alcoholic steatohepatitis 
(NASH), the most worrisome form carrying a higher risk of 
developing liver cirrhosis, and hepatocellular carcinoma (52). A 
gender influence does exist in NAFLD/NASH with men being 
more commonly affected than women (53).
Multiple studies have been recently focusing on the pathways 
leading to the pathological accumulation of TAG in hepatocytes in 
NAFLD/NASH. Dysregulated hepatic FFA export, oxidation and 
desaturation, as well as systemic and hepatic insulin resistance 
are among the main pathways in NAFLD pathogenesis (54, 55). 
Altered glycerol uptake by hepatocytes is also a major intersecting 
component; however, the underlying mechanism has begun to be 
understood only recently, after proving the role played by AQPs 
in facilitating the transmembrane transport of glycerol in adipose 
tissue and liver (56).
A reduction of hepatocyte AQP9 protein with no changes 
in mRNA level was observed in n3-PUFA (ω3 polyunsaturated 
fatty acids)-depleted female rats, a model of metabolic syndrome 
displaying several features of the disease also including hepa-
tosteatosis (57). Increased liver glycerol uptake was observed 
despite the AQP9 downregulation, an apparent discrepancy 
attributed to a raise in GK activity resulting from the altered 
intracellular metabolism. Pathophysiological involvement of 
AQP9 in NAFLD was also found in a study using male rats fed a 
high-fat diet (HFD) where a considerable reduction of the HFD-
induced steatosis was observed after knocking down liver Aqp9 
(54). Our study with ob/ob mice, an animal model of NAFLD, 
showed decreased hepatocyte AQP9 and glycerol permeability 
correlated with increased plasma glycerol, with leptin adminis-
tration restoring hepatic AQP9 levels and hepatosteatosis (47). 
Moreover, surgically induced weight loss is also associated with 
an improvement of the fatty liver in obese rats through the 
restoration of the coordinated regulation of AQPs in the adipose 
tissue and liver (26).
Hepatic AQP9 mRNA was negatively correlated with intra-
hepatic lipid content in obese patients with hepatosteatosis (10, 
17, 19). However, another study did not find any relationship 
between AQP9 expression and the degree of hepatic steatosis 
or fibrosis in patients with morbid obesity (58). Recently, we 
used liver biopsies obtained from a mixed gender cohort of 
morbid obese patients undergoing bariatric surgery showing 
decreased hepatic expression of AQP9 in obese subjects with 
NAFLD (Figure  2) (10). Importantly, the AQP9 diminution 
paralleled the degree of hepatic steatosis, an observation that 
corroborated the notion that lower intrahepatocellular glycerol 
due to a decreased AQP9 expression may represent a compensa-
tory mechanism to reduce the de novo TAG synthesis in fatty 
hepatocytes.
GenDeR-SPeCiFiC DiFFeRenCeS in 
HePATiC HAnDLinG OF GLYCeROL in 
MORBiD OBeSe PATienTS wiTH nAFLD
Obese women Have Lower Hepatic 
Glycerol Permeability Compared to 
Obese Men
Sexual dimorphism in hepatic import of glycerol in fat over-
accumulation was found in a recent work by our group (10). 
A gender separated analysis of hepatic AQP9 regulation was 
performed in obese subjects with NAFLD undergoing bariatric 
surgery. Interestingly, obese women showed significantly lower 
hepatic glycerol permeability when compared with obese men 
(10). Consistent with a previous work by another group (58), 
the hepatic expression of AQP9 was similar between the two 
genders. All women used for this study were in a premeno-
pausal state and females during pregnancy or lactation period 
were excluded, suggesting that the hepatic suppression of 
AQP9 by estrogens seen in female rats during short-term fast-
ing (31) may not apply to humans, at least in morbid obese 
women with NAFLD. Why obese male and female patients 
with NAFLD have comparable hepatic expression of AQP9 
but different glycerol permeability is not known, therefore, 
warranting investigation. Also, whether this disjunction is a 
general trait of humans reflecting gender-specific differences in 
energy-substrate utilization patterns, or it is restricted to mor-
bid obese subjects remains elusive. Human hepatocytes also 
express three other AQPs, such as AQP3, AQP7, and AQP10, 
but to a lower extent than AQP9 (10) and fat overaccumulation 
might involve sex-specific regulation of these glycerol channels 
turning in higher hepatic glycerol permeability in male than 
female subjects. However, this may not be the case for AQP3 
since this AQP was down-regulated in HepG2 cells with oleic 
acid-induced steatosis (59). Sexual-specific changes in the 
lipids composing the hepatocyte plasma membrane during 
hepatosteatosis might constitute another potential explanation. 
The lipid bilayer composing the sinusoidal plasma membrane 
provides an important contribution to the transport of glycerol 
into hepatocytes as proved in our recent work where nearly 
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50% of the glycerol flowing into murine hepatocytes during 
short-term fasting moved by the simple diffusion through the 
membrane lipid bilayer (27).
COnCLUSiOn AnD PeRSPeCTiveS
Taken together, growing evidence points to a potential contribu-
tion of glycerol metabolism and AQPs to the lower prevalence 
of insulin resistance in premenopausal women (Figure 2). The 
mechanisms underlying these gender-specific differences in 
humans include (i) sexual dimorphism in fat distribution, (ii) 
higher lipolysis and AQP7 in visceral fat, and (iii) lower hepatic 
glycerol permeability despite similar expression of AQP9 in 
women. Although rodents do not always represent reliable models 
to assess the relevance of aquaporins in human metabolism and 
energy balance, further investigations pertaining the hormonal 
regulation of AQPs in other metabolic tissues, such as skeletal 
muscle, intestine, pancreas, or heart, will shed more light on 
additional and unexpected metabolic roles of these molecules in 
the coming years.
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